Table 4.

Short-term and long-term outcomes.

	Duct occlusion, n = 48	Fistula, n = 31	No fistula, n = 17	P -value
Clavien-Dindo classification, n (%)
I–II III–IV	41 (85.42) 7 (14.58)	27(87.10) 4 (12.90)	14 (82.35) 3 (17.65)	0.6862
30-days mortality, n (%)	3 (6.45)	2 (6.45)	1 (5.88)	1.0000
90-days mortality, n (%)	2 (4.16)	2 (6.45)	0	1.0000
Short-term outcomes, n (%)
Sepsis Post-operative bleeding Intraddominal collection Pleura effusion Dehiscence* Hemoperitoneum Intestinal obstruction Stroke DIC	11 (22.92) 10 (20.83) 14 (29.17) 2 (4.17) 2 (4.17) 4 (8.33) 2 (4.17) 1 (2.08) 2 (4.17)	9 (29.03) 9 (29.03) 14(45.16) 1 (3.22) 1 (3.22) 2 (6.45) 2 (6.45) 1 (3.22) 2 (6.45)	2 (11.76) 1 (5.88) 0 1 (5.88) 1 (5.88) 2 (11.76) 0 0 0	0.2840 0.0744 < 0.001 1.0000 1.0000 0.2300 0.5328 1.0000 0.5328
Long-term outcomes, n (%)
Brittle diabetes Octreotide therapy	8 (16.67) 44 (91.67)	3 (9.68) 31 (100)	5 (29.41) 13 (76.47)	0.1115 0.0122
Reoperative rate, n (%)
Total Hemostatis Total pancreasectomy GI fistula Re-anastomosis HJ Explorative laparotomy	10(20.83) 4 (8.33) 2 (4.17) 1 (2.08) 1 (2.08) 1 (2.08)	7 (22.58) 2 (6.45) 2 (6.45) 1 (3.22) 1 (3.22) 1 (3.22)	2 (11.76) 2 (11.76) . . . .	0.6073 0.5328 1.0000 1.0000 1.0000
Recurrence, n (%)	7 (14.58)	6 (19.35)	1 (5.88)	0.3956
Follow-up, months
Mean Range	24.5 (3–100)	23.5 (3–100)	17.7 (3–21)
Overall survival (%)	58.3

DIC, disseminated intravascular coagulation; HJ, Hepatico-Jejunostomy;*Dehiscence: 1 Hepatico-jejunostomy; 1 wound.